All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Other antineoplastic agents

Krazati

(adagrasib)

Uses, side effects, dosage information & price range

Bristol-Myers Squibb Pharma EEIG

About this medicine

Krazati as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutation and disease progression after at least one prior systemic therapy.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

OgsiveoComposition: nirogacestatMerck Europe B.V.
Price on RequestView Details →
Bortezomib HospiraComposition: bortezomibPfizer Europe MA EEIG
Price on RequestView Details →
Topotecan HospiraComposition: topotecanPfizer Europe MA EEIG
Price on RequestView Details →
KymriahComposition: tisagenlecleucelNovartis Europharm Limited
Price on RequestView Details →
KinselbyComposition: resminostat4Sc AG
Price on RequestView Details →

Key Information

Salt / Composition

adagrasib

Category

Other antineoplastic agents

Manufacturer

Bristol-Myers Squibb Pharma EEIG

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.